Kakizaki G, Saito T, Soeno T, Sasahara M, Fujiwara Y
Am J Gastroenterol. 1976 May;65(5):437-45.
The parotid saliva test was performed in 146 subjects, including 48 patients with pancreatic disorders, 82 with nonpancreatic disorders and 16 healthy persons. The following results were obtained: 1. The salivary output as well as the maximum bicarbonate concentration and amylase content in the parotid saliva of patients with pancreatic disorders were significantly less than those of patients with nonpancreatic disorders. 2. An abnormal saliva test was found in 83.3% of the patients with the pancreatic disorders. 3. Comparison was made of the parotid saliva test with the pancreozyminsecretin test in regard to diagnostic reliability in 44 subjects, including 22 with pancreatic disorders and 22 with nonpancreatic disorders. The data indicated that, in this series, an abnormal parotid saliva test was 88.6% accurate in diagnosing pancreatic disorders, whereas positive pancreozymin-secretin was only 65.9%.
对146名受试者进行了腮腺唾液检测,其中包括48名胰腺疾病患者、82名非胰腺疾病患者和16名健康人。获得了以下结果:1. 胰腺疾病患者腮腺唾液的分泌量、最大碳酸氢盐浓度和淀粉酶含量明显低于非胰腺疾病患者。2. 83.3%的胰腺疾病患者唾液检测异常。3. 对44名受试者(包括22名胰腺疾病患者和22名非胰腺疾病患者)的腮腺唾液检测和促胰液素-促胰酶素试验的诊断可靠性进行了比较。数据表明,在该系列中,腮腺唾液检测异常对胰腺疾病诊断的准确率为88.6%,而促胰液素-促胰酶素试验阳性率仅为65.9%。